Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook [Yahoo! Finance]
Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $6.00 to $3.50. They now have a "buy" rating on the stock.
Akoya Biosciences, Inc. (NASDAQ: AKYA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $5.00 price target on the stock, down previously from $7.00.